Biogen (BIIB) option implied volatility into Clinical Trials

Biogen (NASDAQ: BIIB) November weekly option implied volatility is at 37, December is at 63; compared to its 52-week range 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Zoetis (ZTS) 1500 contracts of June 85 calls and 1800 contracts of July 80 calls amid cattle screwworm headlines
• Planet Labs (PL) call put ratio 1.4 calls to 1 put as share price down 21%
• Rocket Lab USA, Inc. (RKLB) call put ratio 2.5 calls to 1 put as share price down 4%